Philab Holdings reinstates Navasero

MANILA, Philippines — Philab Holdings Corp. has announced the return of Tom Navasero as chairman following the resignation of incumbent president and CEO Darlene Berberabe.

It would be recalled that Navasero stepped down as chairman of the company last June, citing health reasons.

The board, however, said Navasero is now in good condition to lead the company again.

”I am very excited to rejoin the operating team of the company, and I look forward to executing new business strategies that we have in store,” Navasero said.

“With decades of experience in the industry as our backbone, I believe that we are ready to tackle new challenges ahead of us, and the best is only yet to come,” he added.

Philab has been present in the life sciences and healthcare industry since Navasero’s father, Hector established Philab Industries Inc. in 1958.

Berberabe stepped down effective Oct. 9 through a mutual agreement with the board.

“We have been fortunate to have Lelen’s leadership and mentorship over the past challenging months. On behalf of the entire company, I would like to thank Lelen for her contributions in Philab. We will all miss her passion, leadership and integrity,” said Navasero.

At present, Philab supplies life science equipment, designs and builds laboratories, distributes in-vitro diagnostics tools and now invests in new business ventures focused on genomics.

The company is the country’s first medical holding company focused on investing in health technologies to provide precision medicine using big data and enabling solutions for providing universal healthcare to the Filipinos.

Its subsidiaries include Labit Pte Ltd., a company empowering patients to self testing diagnostics, Medx Pte Ltd., a disruptive Telemedicine company and IntelliGene, a genetics company for consumers.